Is there a Bearish outlook for McKesson Corporation (NYSE:MCK) this week?

October 13, 2018 - By Adrian Mccoy

McKesson Corporation (NYSE:MCK) LogoInvestors sentiment increased to 1.05 in 2018 Q2. Its up 0.15, from 0.9 in 2018Q1. It increased, as 39 investors sold McKesson Corporation shares while 261 reduced holdings. 76 funds opened positions while 238 raised stakes. 172.34 million shares or 3.28% less from 178.18 million shares in 2018Q1 were reported.
Moreover, Aperio Gp Limited has 0.09% invested in McKesson Corporation (NYSE:MCK) for 136,061 shares. Peoples Services Corp, Pennsylvania-based fund reported 100 shares. Inr Advisory Ser Limited Company invested in 0% or 11 shares. Korea Corporation has 62,678 shares. Louisiana State Employees Retirement System holds 0.07% or 11,900 shares in its portfolio. Sun Life Financial, Ontario – Canada-based fund reported 1,349 shares. Raymond James Na owns 0.13% invested in McKesson Corporation (NYSE:MCK) for 15,079 shares. Engineers Gate Manager L P holds 0.46% or 44,184 shares in its portfolio. Virginia Retirement Et Al holds 0.01% of its portfolio in McKesson Corporation (NYSE:MCK) for 3,800 shares. Panagora Asset Mgmt reported 18,647 shares. 210,013 are held by Raymond James And Assocs. Parallax Volatility Advisers L P has 0.03% invested in McKesson Corporation (NYSE:MCK). State Street has invested 0.09% of its portfolio in McKesson Corporation (NYSE:MCK). First Heartland Consultants reported 5,490 shares. Mariner Ltd Liability has invested 0.04% in McKesson Corporation (NYSE:MCK).

Since May 30, 2018, it had 0 insider purchases, and 4 selling transactions for $644,452 activity. On Wednesday, May 30 Lampert Erin M sold $123,256 worth of McKesson Corporation (NYSE:MCK) or 868 shares. 1,350 shares valued at $173,732 were sold by KNOWLES MARIE L/CA on Friday, August 31. JACOBS M CHRISTINE had sold 1,350 shares worth $173,732 on Friday, August 31.

McKesson Corporation (NYSE:MCK) Ratings Coverage

Among 6 analysts covering McKesson (NYSE:MCK), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. McKesson had 6 analyst reports since April 18, 2018 according to SRatingsIntel. On Friday, July 20 the stock rating was downgraded by Robert W. Baird to “Neutral”. The stock of McKesson Corporation (NYSE:MCK) has “Buy” rating given on Wednesday, April 18 by Cowen & Co. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Standpoint Research on Tuesday, July 10. The company was maintained on Friday, July 27 by JP Morgan. Morgan Stanley maintained McKesson Corporation (NYSE:MCK) rating on Tuesday, July 3. Morgan Stanley has “Equal-Weight” rating and $142 target. Leerink Swann maintained it with “Hold” rating and $16000 target in Tuesday, May 29 report. Below is a list of McKesson Corporation (NYSE:MCK) latest ratings and price target changes.

27/07/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $181 New Target: $160 Maintain
20/07/2018 Broker: Robert W. Baird Old Rating: Outperform New Rating: Neutral Downgrade
10/07/2018 Broker: Standpoint Research Old Rating: Hold New Rating: Buy Upgrade
03/07/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $175 New Target: $142 Maintain
29/05/2018 Broker: Leerink Swann Rating: Hold New Target: $160.0000 Maintain
18/04/2018 Broker: Cowen & Co Rating: Buy New Target: $186.0000 Maintain

The stock increased 1.20% or $1.55 during the last trading session, reaching $130.79. About 1.43 million shares traded. McKesson Corporation (NYSE:MCK) has declined 16.67% since October 13, 2017 and is downtrending. It has underperformed by 32.29% the S&P500.

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company has market cap of $26.13 billion. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions. It currently has negative earnings. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.

More news for McKesson Corporation (NYSE:MCK) were recently published by:, which released: “McKesson: Good Enough To Be Great Value” on September 25, 2018.‘s article titled: “Reuters: McKesson’s healthcare tech firm hires banks for IPO” and published on October 03, 2018 is yet another important article.

McKesson Corporation (NYSE:MCK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: